Search results
ASCO 2024: How to Best Use New Breast Cancer Data
Medscape· 4 days agoKevin Kalinsky and Sara Hurvitz discuss the results of awaited data in the breast cancer space presented at the 2024 ASCO Annual Meeting.
Truqap Combo Earns EU Approval for Advanced Breast Cancer
Medscape· 3 days agoThe approval is based on positive results from the phase 3 CAPItello-291 trial.
Promising approach to prevent the recurrence of breast cancer
Digital Journal· 6 days agoA proportion of breast cancers recur even after long periods without signs of cancer remaining...
Pink Ribbon Scramble Helps Women battling breast cancer - KVRR Local News
KVRR· 4 days agoThe Pink Ribbon Scramble at the Maple River Golf Course in Mapleton, North Dakota was founded in...
Pittsburgh woman is 1st patient to receive new early-stage breast cancer vaccine
WPXI via Yahoo News· 3 days agoIn the race for a cure, a Pittsburgh woman is the first patient to receive a new vaccine for early-stage breast cancer. It’s a decision that patient Maria ...
Cancer campaigner 'would be thrilled by response to final message'
BBC via AOL· 6 days agoKate Rackham, pictured with her husband Mark, founded a charity to help women with secondary breast ...
Recommended age to start breast cancer screenings has dropped and doctors see this as a good move
Your Hometown Lima Stations· 3 days agoThe recommended age for women to start screening for breast cancer has dropped, and a local doctor...
On authors against breast cancer, a story of radical hospitality, and the Maine Literary Awards -...
The Boston Globe· 3 days agoAs a way of giving thanks for the breast cancer treatment she received, Cambridge-based author Alice...
AstraZeneca's breast cancer drug combination fails in late-stage trial
Reuters· 6 days ago, opens new tab said on Tuesday its breast cancer drug, Truqap, in combination with chemotherapy...
AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
Zacks· 4 days agoFree Report) announced that the European Commission (EC) has approved Truqap (capivasertib) in combination with Faslodex (fulvestrant) for a breast cancer